Exalenz Bioscience Ltd is an Israel-based company active in the medical sector. It develops and commercializes advanced systems that extract vital information for diagnostics from subtle changes in the patient's exhaled breath. Its core technology enables medical specialists to identify and manage specific digestive and liver conditions. The Company's product, the BreathID System, is used for assessment and monitoring of functional diseases of the liver and gastrointestinal tract. The BreathID System is mobile and can be operated in any clinical setting. The Company conducts ongoing research in collaboration with clinical and industrial partners in the United States, Europe, Asia, and Israel.